Spotlight
Soligenix (NASDAQ: SNGX) Interview with Christopher Schaber, PhD CEO and President
Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Our Specialized BioTherapeutics business segment is developing and moving toward potential commercialization […]
Prodex, Inc Interview with Rick Van Kirk, CEO and President
Interview with Rick Van Kirk, CEO and President […]
Peer To Peer Network (OTC: PTOP) CEO Interview
Joshua Sodaitis, a former licensed stockbroker and venture capitalist, is presently Chairman & CEO of Peer To Peer Network (publicly traded under the stock symbol: PTOP). He is an entrepreneur and inventor with two granted […]
ClearBlue Technologies International (TSXV: CBLU)(OTC: CBUTF)
Clear Blue Technologies International, the leader in Smart Power, was founded on a vision of delivering clean, managed, “wireless power” to meet the global need for reliable, low-cost, solar and hybrid power for lighting, telecom, security, Internet of Things devices, and other mission-critical systems. Today, Clear Blue is working with its customers “On the Road to Zero Diesel”. […]
FingerMotion, Inc (NASDAQ: FNGR)
Interview update with Martin Shen, CEO […]
Prodex, Inc (NASDAQ: PDEX)
Interview update with Rick Van Kirk, CEO […]
Acutus Medical (NASDAQ: AFIB)
Acutus Medical, Inc’s (NASDAQ: AFIB) CEO David Roman recently spoke with Wall Street Analyzer to provide an overview of the company, discuss recent news, and go over key goals for the next 6-8 months. The company is focused on the treatment of atrial fibrillation and other cardiac arrhythmias and has a novel mapping system that enables physicians to visualize disease on a patient by patient basis and therefore has a higher success rate than current standard of care procedures. Mr. Roman went over AFIB’s recent Q3 results that included an over 50% increase in their international procedures and a 17% year to year growth in overall procedures. Perhaps the biggest announcement was the company’s deal with Medtronic for sale of their access portfolio, referred to as Left Heart Access (LHA), and consists of uncapped revenue based earn-outs for four years after the official launch. Acutus Medical produced $17.3 million in revenue in 2021. […]
Zerify (OTCQB: ZRFY)
Interview with Mark Kay, CEO and Chairman […]